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Abstract 
Purpose: To establish a double polymerase chain reaction (PCR) method for the simultaneous 
detection of African swine fever virus (ASFV) and swine vesicular disease virus (SVDV). 
Methods: By using reference sequences of ASFV and SVDV, this study synthesized parts of the genes 
connected to the 19-T vector which was inserted into competent DH5α cells to establish recombinant 
plasmids. Two specific primers of ASFV P72 proteins and SVDV genome were designed to amplify the 
two target genes. Two pairs of primers and two kinds of recombinant plasmids were added to one PCR 
reaction system to establish a double PCR assay for detection of the two diseases simultaneously. The 
double PCR conditions were optimized and the sensitivity and specificity of the assay determined. 
Results: The reaction was optimal with a final concentration of 0.36 μM for each primer, and a final 
annealing temperature of 55.5 oC. The lowest target gene copy number for detecting SVDV and ASFV 
was 7.6 × 102 and 1.5×105 copies/µL, respectively. The assay has a high level of specificity as only the 
recombinant plasmids of ASFV and SVDV were amplified and control plasmids for three other diseases 
- porcine circovirus (PCV), pseudorabies virus (PRV), and porcine parvovirus (PPV) - failed 
amplification. 
Conclusion: This study provides a rapid, sensitive and specific double PCR method for the 
simultaneous detection of ASFV and SVDV. 
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African swine fever (ASF) is an acute, febrile, 
highly contractive and infectious swine disease 
caused by African swine fever virus (ASFV) [1-3]. 
ASFV is a double-stranded DNA virus with an 
outer membrane coating that has a complex 20 
sided symmetry, and a viral genome which is 170 
kb-190 kb in overall length and which is currently 
the only known arbovirus with DNA as its nucleic 
acid [4]. The clinical manifestations of ASF are 
quite similar to those of swine fever [5], which 
include acute fever, accompanied with systemic 
bleeding and hemorrhage in all the organs. The 
clinical symptoms range from acute, sub-acute 
and chronic, manifesting as high fever, skin 
cyanosis, respiratory disorders and neural 
symptoms. Once swine is infected with ASF, 
both the morbidity and mortality can reach 100 % 
[6]. ASF is listed as one of the major seven swine 
diseases by OIE and is a Class 1 disease in the 
list of animal pathogenic microbes in China [7]. 
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ASFV can encode more than 34 structural 
proteins, amongst which the P72 protein can 
serve as a nucleocapsid protein. The P72 protein 
is a major structural protein of ASFV, which 
accounts for 32 % of its virion protein content 
and has a stable antigenicity [8,9]. ASFV is one 
of the few viruses which cannot react to 
neutralization reactions and is conserved across 
different strains [10]. Therefore, it is the most 
common target antigen for detecting ASFV 
[11,12]. 
 
Swine vesicular disease (SVD) is an acute and 
febrile infectious disease caused by the swine 
vesicular disease virus (VDV), which is listed as 
a Class A infectious disease by OIE [13]. 
Belonging to small RNA Circoviride Enterovirus, 
SVDV is a single-stranded positive RNA, virus 
whose genome is 7400 bp in length [14,15]. The 
genome of SVDV has a large open reading 
frame which encodes a strain of polyprotein 
containing 2185 amino acids which produces P1, 
P2 and P3 by primary pyrolysis. G-C pairs 
present at low frequency in the base 
composition, which conforms to that of other 
enterovirus. The clinical symptoms of this 
disease feature as blisters or festering of the oral 
and nasal mucosa and at hoofs causing serious 
public health problems. 
 
At present, the major laboratory methods for 
detecting SVD include ELISA detection [16,17], 
conventional RT-PCR detection and real-time 
fluorescence RT-PCR detection; each method 
has associated advantages and disadvantages. 
  
The aim of the paper was to establish a PCR-
based assay that can simultaneously detect 
ASFV and SVDV with high sensitivity and 
specificity and provide an effective tool for the 
diagnosis and effective prevention of African 







2 × Taq PCR MasterMix, DNA Marker DL2000, 
pMD® 19-T Vectors were purchased from 
TaKaRa (Japan). Agarose was obtained from 
Biowest, and Column DNABACK obtained from 
the Beijing Tian En Ze Gene Technology Co., 
Ltd. Competent E. coli DH5α was prepared and 
preserved by Animal Quarantine Laboratory of 
Sichuan Agricultural University.  
 
Design and synthesis of primers 
 
Amplification primers: Primers were carefully 
designed using DNAMAN according to the 
sequences data of the ASFV and SVDV 
published in GenBank (ASFV log-in ID: 
AY578708 and SVDV log-in ID: EU151461.1). All 
primers were prepared by TaKaRa. Table 1 
shows the sequences of each of the amplification 
primers. 
 
Synthetic primers of target genes: ASFV (log-in 
ID: AY578708) and SVDV (log-in ID: 
EU151461.1) sequences were downloaded from 
NCBI and primers designed by DNAstar. The 
length of the ASFV target fragment was 235 bp, 
and the length of SVDV target fragment was 358 
bp. Table 2 shows the sequences of the 
synthetic primers of ASFV, and Table 3 shows 
the sequences of the synthetic primers of SVDV. 
 
Synthesis of target segment 
 
The conserved segment sequence fragments of 
ASFV and SVDV were synthesized in vitro by an 
overlap extension PCR method using synthetic 
primers. The primary extension reaction system 
included 5 μL of 10×Pfu DNA polymerase buffer, 
1 μL of Pfu DNA polymerase, 4 μL of dNTP (10 
mM), 1 μL of bypass primers (F1-4/R1-4) (10 
mM), and 38 μL of double distilled water. 
Table 1: The sequences of amplification primers 
 
Pathogen Primer sequence Product size (bp) 
ASFV AP1:5’-AACAGCAGGTAAACAAGA-3’ AP2:5’- ATCCTTTTGCGATGC-3’ 235 
SVDV SP1:5’- CCTCAATTCTCCGTCAGC -3’   SP2:5’- GAACTTGGATGCGTTACACT -3’ 358 
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All the primers were diluted to a concentration of 10 μM according to the manufacturer’s instructions and stored 
at -20 oC 
 
The secondary extension reaction system 
included 20 μL of two adjacent reaction product 
from the previous bypass and extension 
reactions each, 1 μL of Pfu DNA polymerase, 1 
μL of 10×Pfu DNA polymerase buffer, and 8 μL 
of dNTP (10 mM). 
 
Primary and secondary extension reactions were 
conducted at 94 oC for 30 s and 72 oC for 15 min, 
respectively. 
 
Amplification and identification of target 
genes 
 
The 50 µL reaction system contained 25 µL of 2 
× Taq PCR MasterMix, 18 µL of double distilled 
water, 1 µL of ASFVP1, 1 µL of ASFVP2, 1µL of 
SVDVP1, 1 µL of SVDVP2 and 3 µL of products 
from the secondary extension reaction. The 
amplification reaction was performed at 94 oC for 
4 min (initial denaturation), 94 oC for 50 s 
(denaturation), 55 oC for 45 s (annealing), 72 oC 
for 1 min (extension) for 30 cycles ending at 72 
oC for 10 min (overall extension). PRC products 
were stored at -20 oC. 
 
The PCR products were detected using 1 % 
agarose gel electrophoresis and connecting the 
products to a pMD® 19-T Vector after gel 
extraction and purification. A 10 uL reaction 
system contained 5 μL of solution I, 1 μL of 
pMD® 19-T Vector, and 4 μL gel extraction 
products. The reaction system was maintained at 
16 oC overnight and inserted into competent 
DH5α cells for cloning. The bacterial liquid was 
aliquoted into different EP tubes at a ratio of 7:3 
(bacterial liquid: glycerine). Samples were 
processed for sequencing analysis and others 
were stored at -70 oC. 
 
Establishment of double PCR method 
 
An aliquot of 20 μL of the double PCR system 
contained ASFVP1, ASFVP2, SVDVP1 and 
SVDVP2 in the same system (the concentration 
range of the primers is 0.04 - 0.6 μM), 10 μL of 2 
× Taq PCR MasterMix, 2 μL of ASFV bacterial 
liquids, 2 μL of SVDV bacterial liquids and 
double distilled water. In order to optimize the 
annealing temperature, 50, 51, 52.9, 55.5, 59.1, 
62, 63.8 and 65 oC were selected to test 
reactions. The reaction procedure was as follow: 
95 oC for 5 min, 94 oC for 30 s, annealing 
temperatures for 45 s, 72 oC for 30 s, 30 cycles, 
ending at 72 oC for 10 min. The PCR products 





The specificity of double PCR with the two pairs 
of specific primers was assessed by comparing 
the recombinant plasmids containing the target 
ASFV and SVDV fragments to the Porcine 
circovirus (PCV), Porcine pseudorabies (PRV), 




To assess the sensitivity, the recombinant 
plasmids constructs were measured using a ND-
1000 ultraviolet spectrophotometer (Nano Drop 
Co, Ltd, USA) and amplified in a 10-fold serial 
dilution by PCR using the optimum reaction 
system and conditions as described above. 
Quantitative results showed that the 
concentration of the ASFV and SVDV gel 
extraction products were 40 ng/µL and 30 ng/µL 
respectively. The calculation formula of gene 
copy number concentration is: (6.02 × 1023) × 
(sample concentration ng/µL×10-9)/(DNA length × 




Amplification and identification of target 
genes 
 
The recombinant plasmids of ASFV and SVDV 
were used as the templates and amplified by the 
specific primers of ASFV and SVDV. The 
reaction products were detected by 1 % agarose 
gel electrophoresis. The results showed that 
ASFV and SVDV amplify fragments at the 
lengths of 235 bp and 358 bp respectively, which 
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conformed to the length of expected target gene 




Fig 1: Identification of recombinant plasmids. Note: 1 
= negative control; 2 = recombinant plasmids; and 3 = 
DNA marker DL2000 
 
The previously selected target genes of ASFV 
and SVDV were compared for homology (in 
www.NCBI.com) and the results showed 100 % 
homology, indicating that the target genes are 
correctly synthesized. 
 
Optimization of double PCR reaction 
conditions 
 
Optimization of annealing temperature 
 
The optimal anneal temperature results are 
shown in Fig. 2. In consideration of the effect of 
temperature on annealing and specificity, the 




Fig 2: Optimization of annealing temperature. Note: M 
= DNA marker DL2000; 1 = negative control; 2 – 9 = 
annealing temperature of 65, 63.8, 62, 59.1, 55.5, 
52.9, 51 and 50 oC, respectively 
 
 
Optimization results of primer concentration 
When the final concentration of each specific 
primer reached 0.04~0.6 μM, the amplification 
results are as shown in Fig. 3. For reaction 
efficiency and reduction of primer dimmer 
formation, the optimal final concentration of 




Fig. 3: Optimization of primer concentration. Note: M 
= DNA marker DL2000; 1 – 12 = respective primer 
concentration 0.6, 0.48, 0.36, 0.3, 0.24, 0.2, 0.18, 
0.16, 0.12, 0.08, 0.06 and 0.04 μM 
 
Specificity results from double PCR 
 
PCR amplification of ASFV, SVDV, PCV, PRV 
and PPV using the optimized double PCR 
conditions are shown in Fig. 4. Lane 4 
demonstrates the only amplification specific 
products at lengths of 235 bp and 358 bp. The 
amplification results of PCV, PRV and PPV 
pathogens are all negative, indicating that the 
double PCR method is highly specific. 
 
 
Fig 4: Specificity results. Note: 1 – 3 = PCV, PRV, 
and PPV, respectively; M = DNA marker DL2000; 4 = 
mixed bacterial liquids of ASFV and SVDV 
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Sensibility experiment on double PCR 
 
The results of sensibility experiment are shown in 
Fig. 5. It is observed from Fig. 5 that SVDV in 
lane 2 still presents obvious specific amplification 
with a sensitivity to the target genes of 7.6×102 
copies/µL. ASFV in lane 4 presents obvious 
specific amplification with a sensitivity to the 
target genes of 1.5×105 copies/µL. 
 
 
Fig 5: Sensibility results. Note: 1 - 10 = ASFV target 
genes copy numbers, viz, 1.5×102, 1.5×103, 1.5×104, 
1.5×105, 1.5×106, 1.5×107, 1.5×108, 1.5×109, 1.5×1010 
and 1.5×1011 copies/µL, respectively: 1-10 = SVDV 
target genes copy numbers, viz, 7.6×101, 7.6×102, 
7.6×103, 7.6×104, 7.6×105, 7.6×106, 7.6×107, 7.6×108, 
7.6×109 and 7.6×1010 copies/µL, respectively; M = 




ASF is a serious disease that can cause huge 
economic losses in the swine industry. The 
number of swine in China accounts for half of the 
total number in the world and our consumption of 
pork is ever increasing, which requires increasing 
quantity of pork imported from abroad. Therefore, 
the development of a healthy and robust swine 
industry is extremely important and has a 
significantly influences the food safety and 
national security in China.  
 
Currently, there is no ASFV in China and ASF 
epidemics in the adjacent areas between Russia 
and China. However, the constant spreading of 
ASF epidemics within Russia and the frequent, 
rapid and long-distance trading of animals and 
commodities around the globalized world make it 
increasingly difficult to guarantee that food is free 
from pathogenic bacteria, virus or epidemics, 
such as ASFV. Therefore, we must remain on 
high alert and conduct risk analysis to prevent 
ASF from entering in China [18]. Besides, SVD’s 
damage to swine industry has been continuously 
increased in recent years. Therefore, it is 
significant for ensuring the healthy development 
of swine industry in China by establishing a rapid 
and accurate method for simultaneously 
detecting ASF and SVD. 
 
To our knowledge, many available techniques 
such as RT-PCR, real-time RT-PCR and ELISA 
have been developed for ASFV detection in the 
endemic areas, but there was few studies on 
ASFV including the ASFV detecting methods in 
China and some other non-endemic countries 
because ASF have not happened in the 
boundary regions and there is no ASF strains 
used for researches in China. 
 
This study designs two kinds of specific primers 
for ASFV P72 proteins and SVDV genome 
respectively and synthesizes target genes. By 
optimizing the annealing temperature and other 
reaction conditions for the double PCR assay, 
this study guarantees the amplification efficiency 
of the two couples of specific primers in the 
specific reaction. The double PCR method 
established in this study can rapidly detect and 
identify ASFV and SVDV in one reaction system. 
It shows good specificity and sensitivity, and can 
be directly used for the detection of clinical 
epidemic materials in samples, offering an 
effective tool for the diagnosis, and prevention 
and control of ASF and SVD. It was the first time 
to establish an assay to detect the two diseases 
simultaneously in China. In conclusion, the 
designed primers and the double PCR described 
in this paper supplied important materials and a 
rapid useful technological reserve for ASFV and 
SVDV detection and set basis for the studies 




The findings indicate that double PCR approach 
is a rapid, sensitive and specific method for 
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